HOME >> MEDICINE >> NEWS
Researchers seek new hope in old asthma treatment

Theophylline (pronounced theeoffaleen), an asthma medication prescribed since the 1950s, is now being studied for new potential merits. The Effectiveness of Low Dose Theophylline as Add-On Therapy in the Treatment of Asthma or LODO trial is sponsored by the 19 American Lung Association (ALA) Asthma Clinical Research Centers (ACRC) across the country and seeks to enroll over 600 people, age 15 and over, who suffer from persistent asthma symptoms despite treatment. The ALA ACRC at the University of Vermont (UVM), headed by Professor of Medicine and Vermont Lung Center Director Charles Irvin, Ph.D., is the lead study site.

An estimated 26 million Americans have been diagnosed with asthma. About a third of all asthma sufferers are unable to manage their asthma well, Irvin said. The LODO study aims to test its effectiveness as an add-on therapy for this population.

Theophylline is a pill-form asthma treatment classified as a bronchodilator that has been used for over 50 years to help open narrow, inflamed airway passages. The medication became associated with side effects and drug interactions and fell out of favor when newer treatment options became available. Recent studies in such scientific journals as The Lancet and the American Journal of Respiratory Critical Care Medicine suggest that theophylline may have the capacity to reduce airway inflammation and clear away mucus in doses one-quarter to one-third of those needed to open asthmatic passages. So scientists decided to give theophylline another chance.

The LODO study seeks to identify whether or not theophylline can be an effective add-on therapy a booster, so to speak that will produce better overall results for asthmatics. The study will compare the effectiveness and side-effects of low doses of theophylline to montelukast (sold as Singulair), as well as placebo (sugar pill), on asthma patients. During the double-blind study, the patient, the doctor and the research staff
'"/>

Contact: Jennifer Nachbur
jennifer.nachbur@uvm.edu
802-656-7875
University of Vermont
10-May-2002


Page: 1 2

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
8. Researchers offer emergency workers a lifeline
9. Researchers discover genetic variant that may explain why women develop M.S. more than men
10. Researchers map the sexual network of an entire high school
11. Researchers hope monkeys can provide new insights into depression

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Little Rock, AR (PRWEB) , ... October 13, ... ... owned firm with locations throughout Arkansas that offers insurance and financial preparation services, ... to benefit the Rock City Rescue organization. , Rock City Rescue is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) ... and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton ... until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare ... CPR training aide "cprCUBE" on Kickstarter. The device will ... during cardiac arrests with better efficiency compared to the ... offers real-time feedback on efficacy of the compression for ... campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
Breaking Medicine Technology:
Cached News: